NDC Package 0007-4887-13 Requip XL

View Billable Units, 11-Digit Format, RxNorm

Package Information
Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

0007-4887-13

Package Description:

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE

Product Code:

0007-4887

Proprietary Name:

Requip XL

Usage Information:

This medication is used alone or with other medications to treat Parkinson's disease. It can improve your ability to move and decrease shakiness (tremor), stiffness, slowed movement, and unsteadiness. It may also decrease the number of episodes of not being able to move ("on-off syndrome"). Ropinirole is also used to treat restless legs syndrome (RLS). It may improve your sleep by decreasing the urge to move your legs and decreasing uncomfortable/unpleasant feelings in the legs. This medication works by helping to restore the balance of a certain natural substance (dopamine) in the brain.

11-Digit NDC Billing Format:

00007488713

Billing Unit:

EA - Billing unit of "each" is used when the product is dispensed in discreet units.

NDC to RxNorm Crosswalk:

30 EA

Labeler Name:

Glaxosmithkline Llc

Sample Package:

FDA Application Number:

NDA022008

Marketing Category:

NDA - A product marketed under an approved New Drug Application.

Start Marketing Date:

06-30-2008

End Marketing Date:

09-30-2020

Listing Expiration Date:

09-30-2020

Exclude Flag:

Code Structure:

0007 - Glaxosmithkline Llc
- 0007-4887 - Requip
  - 0007-4887-13 - 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 0007-4887-13?

The NDC Packaged Code 0007-4887-13 is assigned to a package of 30 tablet, film coated, extended release in 1 bottle of Requip XL, labeled by Glaxosmithkline Llc. The product's dosage form is and is administered via form.

Is NDC 0007-4887 included in the NDC Directory?

No, Requip XL with product code 0007-4887 is excluded from the NDC Directory because it was discontinued by the manufacturer. The product was first marketed by Glaxosmithkline Llc on June 30, 2008 and its listing in the NDC Directory is set to expire on September 30, 2020 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 0007-4887-13?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 30.

What is the 11-digit format for NDC 0007-4887-13?

The 11-digit format is 00007488713. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
4-4-2	0007-4887-13	5-4-2	00007-4887-13

Table of Contents